日期: 2025年3月3日

Global Advanced Metals连续15年符合矿产尽职调查审计标准

宾夕法尼亚州博耶敦, 2025年3月3日 - (亚太商讯 via SeaPRwire.com) - Global Advanced Metals Pty Ltd (GAM)是一家领先的钽和锡产品生产商，其位于澳大利亚、日本和美国的三家制造工厂成功通过了负责任矿产倡议（RMI）下的负责任矿产保障流程（RMAP）的冲突矿产尽职调查审计。 GAM 在尽职调查和负责任矿产贸易方面取得了新的里程碑。经过2024年8月和9月的审计，RMAP-RMI 认定 GAM 位于日本会津（Aizu）、澳大利亚西澳格林布什（Greenbushes, WA）和美国宾夕法尼亚州博伊尔镇（Boyertown, Pennsylvania）的工厂符合其针对钽和锡的审计标准。 要获得 RMAP-RMI 的合规认证，公司必须成功通过严格的第三方冶炼厂运营审计。该审计包括验证以下内容：遵循经济合作与发展组织（OECD）的五步尽职调查指南，合理的原产国评估，矿山来源及供应链追溯文件，以及废料来源验证等多项标准。 GAM 全球供应链高级总监爱德华·斯泰克尔（Edward Steckel）表示：“这些成功的审计进一步证明了 GAM 以整体管理体系为核心的矿产尽职调查方法的有效性。GAM 将继续与负责任矿产贸易公私联盟（PPA）、负责任矿产倡议（RMI）、经济合作与发展组织（OECD）多方利益相关者小组等组织合作，推动矿产行业的负责任商业实践。” RMI-RMAP 的冲突矿产尽职调查审计项目由多个行业（如电子、航空航天、汽车）、政府及其他利益相关方共同领导和支持。下游企业依赖 GAM 等符合标准的冶炼厂，以确保遵守美国《多德-弗兰克法案》第1502条、欧盟冲突矿产法规及其他适用的无冲突矿产法规。关于 GAMGlobal Advanced Metals (GAM）是一家领先的无冲突钽和锡产品制造商。GAM 拥有全球最大工业级钽矿资源的独家开采权，该矿位于澳大利亚西部。GAM 在美国宾夕法尼亚州和日本会津的工厂生产无冲突钽粉末无冲突钽粉末和冶金产品，广泛应用于电子、航空航天、汽车、医疗及化工等行业。此外，GAM 还在澳大利亚西澳格林布什工厂生产锡锭。GAM 位于日本和美国的冶炼设施最早于2010年在前电子工业公民联盟（EICC）/全球电子可持续发展倡议（GeSI）的无冲突采购倡议（CFSI）审计计划下获得“无冲突”认证，并持续符合当前负责任矿产保障流程（RMAP）的标准。关于 RBA、RMI 和 RMAP负责任商业联盟（RBA），前身为电子工业公民联盟（EICC）。负责任矿产倡议（RMI），前身为无冲突采购倡议（CFSI）。负责任矿产保障流程（RMAP），前身为无冲突冶炼厂计划（CFSP）。联系信息Jean-Paul MeutchehoDirestor of Sourcing and Corporate Sustainabilityjmeutcheho@globaladvancedmetals.com+1 610-369-8165来源: Global Advanced Metals Copyright 2025 亚太商讯 via SeaPRwire.com.

More

NEC develops and commercializes 5G-compatible virtualized base stations (vRAN)

SINGAPORE, Mar 3, 2025 - (ACN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has developed and commercialized software for virtualized radio access network (vRAN) base stations. The company aims to provide this software to telecommunications carriers in Japan and internationally, and to deploy more than 50,000 vRAN base stations by fiscal 2026.vRAN is a system that will serve as the foundation for the development of network technologies in the future, including further enhancement of 5G services, optimization and streamlining of operational costs, flexible network design, accelerated area deployment, and collaboration with the Innovative Optical and Wireless Network (IOWN®) concept proposed by NTT. This is expected to facilitate the development and introduction of new technologies through Open RAN, and promote innovation while reducing power consumption.NEC's vRAN achieves carrier-grade network quality that complies with the specifications defined by the O-RAN ALLIANCE (*1). In addition, because it complies with open interface specifications, it is guaranteed to work in conjunction with equipment from different vendors and cloud environments. By using this software, it is possible to achieve a RAN configuration that is optimal for the specifications required by telecommunications carriers. In addition, it uses a fully containerized architecture and is based on 5G hardware base station technology and knowledge that is cloud-native, has a proven track record of large-scale commercial use, and it is compatible with cutting-edge general-purpose servers. Furthermore, it uses Qualcomm Technologies' inline accelerator, the Qualcomm Dragonwing X100, to speed up processing, and achieves the high speed and large capacity communications that are characteristic of 5G.NEC has already deployed a 5G core network (5GC, *2) that uses virtualization technology, and the commercialization of this software for vRAN will enable the construction of a total cloud-native 5G network from the core to the RAN. This will make it possible to provide a high-quality 5G network that can flexibly respond to diverse service requirements.Furthermore, by utilizing this software, resource reallocation through virtualization is possible, enabling as much as a 65% reduction in total device power consumption when compared to existing 5G base station equipment (*3).In addition, NEC has developed a Near Real-time RAN Intelligent Controller (Near-RT RIC) to enhance the functionality of vRAN. This enables dynamic customization of RAN operation in response to diversifying service demands, and enables functional expansion such as quality improvement, SLA guarantees, and power saving (*4). Moreover, when combined with NEC's solutions for advanced network operation management, the construction time for mobile infrastructure can be reduced by approximately 70% compared to conventional methods, enabling large-scale commercial deployment of 5G networks in a short period of time."NEC is excited to announce the commercialization of our vRAN software, which will play a critical role in shaping the future of network technologies," said Takashi Sato, Corporate Senior Vice President at NEC. "Our vRAN solution not only adheres to strict O-RAN ALLIANCE specifications but also leverages open interfaces and a fully containerized architecture to ensure optimal integration with multi-vendor and cloud environments.""We are very pleased to see our strong collaboration with NEC moving forward with commercial deployment of the Virtualized Distributed Unit (vDU) using the Qualcomm Dragonwing X100 accelerator card," said Gerardo Giaretta, VP & GM of 5G RAN Infrastructure, Qualcomm Technologies, Inc. "This collaboration demonstrates our commitment to delivering high-performance, energy-efficient and cost-effective 5G solutions that meet the evolving needs of network operators around the world."Going forward, NEC will continue to work towards providing high-performance 5G networks that are geared towards 5G Advanced and 6G, as well as networks with high scalability and flexibility that can respond to diversifying service requirements.(1) O-RAN ALLIANCE:An international industry organization that promotes standardization with the aim of realizing open and scalable next-generation wireless access networks, including 5G.(2)5G core (5GC)A mobile core network system that accommodates 5G wireless.(3)Based on NEC's evaluation criteria.(4)Press release: NEC Develops Near Real-time RIC for High Performance 5G vRAN www.nec.com/en/press/202502/global_20250221_02.htmlAbout NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 ACN Newswire via SeaPRwire.com.

More

The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer’s Disease

TOKYO and CAMBRIDGE, Mass., Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has reaffirmed its positive opinion by consensus for the anti-Aβ monoclonal antibody lecanemab, adopted in November 2024.(1) Following CHMP’s reaffirmation, after having considered the additional information requested by the European Commission (EC), the EC will resume the decision-making process for lecanemab's marketing authorization.In January 2025, as part of its decision-making process, the EC asked the CHMP to consider information on the safety of lecanemab that became available after the adoption of the CHMP opinion in November 2024 and whether this may require anupdate of the opinion, and to consider whether the wording of the risk minimization measures in the opinion is clear enough to ensure correct implementation. After reviewing the additional information, the CHMP concluded that its positive opinion for lecanemab does not need to be updated.Mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and AD dementia currently affects an estimated 15.2 million and 6.9 million people in Europe, respectively.(2) AD progresses over time in stages with increasingly severe symptoms that greatlyimpact not only those who are living with AD, but also their loved ones, care partners and society. There is a significant unmet need for new treatment options that slow down the progression of AD from its early stage.If the EC approves the lecanemab marketing authorization application, the approval will apply to all 27 European Union member states, as well as Iceland, Liechtenstein, and Norway. Eisai and Biogen will continue to make every effort to deliver lecanemab to patients with early AD in Europe as soon as possible.Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision- making authority.About lecanemab (generic name, brand name: Leqembi®)Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ).Lecanemab has been approved in the U.S.,(3) Japan,(4) China,(5) South Korea,(6) Hong Kong,(7) Israel,(8) the United Arab Emirates,(9) the United Kingdom,(10) Mexico,(11) Macau and Oman, and is under regulatory review in 17 countries and regions including theEU. In January 2025, the U.S. Food and Drug Administration (FDA) has approved the Supplemental Biologics License Application (sBLA) for once every four weeks maintenance dosing. In January 2025, the submission of a Biologics License Application (BLA) for maintenance dosing of a subcutaneous injection formulation, which is being developed to enhance convenience for patients, was accepted in the U.S.Since July 2020 the Phase 3 clinical study (AHEAD 3-45) for individuals with preclinical AD, meaning they are clinically normal and have intermediate or elevated levels of amyloid in their brains, is ongoing. AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School ofMedicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.About the Collaboration between Eisai and Biogen for ADEisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisai serves as the lead of lecanemab development and regulatory submissions globally with both companies co-commercializing and co-promoting the product and Eisai having final decision-making authority.About the Collaboration between Eisai and BioArctic for ADSince 2005, Eisai and BioArctic have had a long-term collaboration regarding the development and commercialization of ADtreatments. Eisai obtained the global rights to study, develop, manufacture and market lecanemab for the treatment of AD pursuant to an agreement with BioArctic in December 2007. The development and commercialization agreement on the antibody lecanemab back-up was signed in May 2015.About Eisai Co., Ltd.Eisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase thebenefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim toeffectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), by working on various activities together with global partners.For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai Co., Ltd.), and connect with us on X, LinkedIn and Facebook. The website and social media channels are intended for audiences outside of the UK and Europe. For audiences based in the UK and Europe, please visit www.eisai.eu and Eisai EMEA LinkedIn.  About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.The company routinely posts information that may be important to investors on its website at www.biogen.com. Follow Biogen on social media – Facebook, LinkedIn, X, YouTube.Biogen Safe HarborThis news release contains forward-looking statements, including about the potential clinical effects of lecanemab; the potential benefits, safety and efficacy of lecanemab; potential regulatory discussions, submissions and approvals and the timing thereof; the treatment of Alzheimer's disease; the anticipated benefits and potential of Biogen's collaboration arrangements with Eisai; the potential of Biogen's commercial business and pipeline programs, including lecanemab; and risks and uncertainties associated with drug development and commercialization. These forward- looking statements may beaccompanied by such words as “aim,” “anticipate,” “assume,” “believe,” “contemplate,” “continue,” “could,” “estimate,”“expect,” “forecast,” “goal,” “guidance,” “hope,”“intend,” “may,” “objective,” “plan,” “possible,” “potential,” “predict,” “project,” “prospect,” “should,” “target,” “will,” “would,” and other words and terms of similar meaning. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early-stage clinicaltrials may not be indicative of full results or results from later stage or larger scale clinical trials and do not ensure regulatory approval. You should not place undue reliance on these statements. Given their forward-looking nature, these statements involve substantial risks and uncertainties that may be based on inaccurate assumptions and could cause actual results to differ materially from those reflected in such statements. These forward-looking statements are based on management's current beliefs and assumptions and on information currently available to management. Given their nature, we cannot assurethat any outcome expressed in these forward-looking statements will be realized in whole or in part. We caution that thesestatements are subject to risks and uncertainties, many of which are outside of our control and could cause future events or results to be materially different from those stated or implied in this document, including, among others, uncertainty of long- term success in developing, licensing, or acquiring other product candidates or additional indications for existing products; expectations, plans and prospects relating to product approvals, approvals of additional indications for our existing products,sales, pricing, growth, reimbursement and launch of our marketed and pipeline products; our ability to effectively implementour corporate strategy; the successful execution of our strategic and growth initiatives, including acquisitions; the risk thatpositive results in a clinical trial may not be replicated in subsequent or confirmatory trials or success in early stage clinicaltrials may not be predictive of results in later stage or large scale clinical trials or trials in other potential indications; risks associated with clinical trials, including our ability to adequately manage clinical activities, unexpected concerns that may arisefrom additional data or analysis obtained during clinical trials, regulatory authorities may require additional information orfurther studies, or may fail to approve or may delay approval of our drug candidates;the occurrence of adverse safety events, restrictions on use with our products, or product liability claims; and any other risksand uncertainties that are described in other reports we have filed with the U.S. Securities and Exchange Commission.These statements speak only as of the date of this press release and are based on information and estimates available to us at this time. Should known or unknown risks or uncertainties materialize or should underlying assumptions prove inaccurate, actual results could vary materially from past results and those anticipated, estimated or projected. Investors are cautioned not to put undue reliance on forward-looking statements. A further list and description of risks, uncertainties and other matterscan be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and in our subsequent reports on Form 10-Q and Form 10-K, in each case including in the sections thereof captioned “Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in our subsequent reports on Form 8-K. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements whether as a result of any new information, future events, changed circumstances or otherwise.(1) Committee for Medicinal Products for Human Use. 2024. Leqembi (Lecanemab).Overview. Available at: www.ema.europa.eu/en/medicines/human/EPAR/leqembi#overview Last accessed: January 2025(2) Gustavsson, A., et al. Global estimates on the number of persons across the Alzheimer's disease continuum. Alzheimer’s & Dementia.2023;19:658-670. https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12694. (3) U.S. Food and Drug Administration. 2023. FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval. Last accessed: January 2025.(4) Reuters. 2023. Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen. Last accessed: January 2025.(5) The Pharma Letter. 2024. Brief - Alzheimer drug Leqembi now approved in China. Last accessed: January 2025.(6) Pharmaceutical Technology. 2024. South Korea’s MFDS approves Eisai-Biogen’s LEQEMBI for Alzheimer’s. Last accessed: January 2025.(7) Pharmaceutical Technology. 2024. Hong Kong approves Leqembi for Alzheimer’s treatment. Last accessed: January 2025.(8) Pharmaceutical Business Review. 2024. Leqembi gains approval for Alzheimer’s treatment in Israel. Last accessed: January 2025.(9) United Arab Emirates Ministry of Health & Prevention. 2024. Registered Medical Product Directory. Leqembi. Last accessed: January 2025.(10) Lecanemab United Kingdom Summary of Product Characteristics. Available at: www.medicines.org.uk/emc/product/15908. Last accessed: January 2025.(11) The Pharma Letter. 2024. BRIEF-Mexican approval for Alzheimer’s drug Leqembi. Available at: www.thepharmaletter.com/brief-mexican-approval-for-alzheimers-drug-leqembi. Last accessed: January 2025.MEDIA CONTACTSEisai Co., Ltd.Public Relations Department TEL: +81 (0)3-3817-5120Eisai Europe, Ltd.EMEA Communications Department+44 (0) 797 487 9419Emea-comms@eisai.netEisai Inc. (U.S.)Libby Holman+1-201-753-1945Libby_Holman@Eisai.comBiogen Inc.Jack Cox+ 1-781-464-3260public.affairs@biogen.comINVESTOR CONTACTSEisai Co., Ltd.Investor Relations Department TEL: +81 (0) 3-3817-5122Biogen Inc.Tim Power+ 1-781-464-2442IR@biogen.com Copyright 2025 JCN Newswire via SeaPRwire.com.

More

联想控股料2024全年亏损收窄或扭亏为盈

香港, 2025年3月3日 - (亚太商讯 via SeaPRwire.com) - 据财华网报道，2月28日，联想控股（3396.HK）发布正面盈利预告，公司董事会对截至2024年底之未经审核综合管理账目作出初步审阅，预期2024年度归母净利润介乎亏损约8亿元至盈利约3亿元（人民币，下同），同比2023年度有大幅收窄或扭亏为盈。据公告显示，公司2024年度业绩改善的主要原因之一是旗下联想集团业绩同比大幅增长。过去一年，联想集团专注于混合式人工智能，在AIPC发展浪潮中占得先机。根据其二零二四/二五年三季报，联想集团纯利同比增长106%，收入同比增长至188亿美元，创过去三年最高季度销售额，同时其三个业务的收入均连续第三个季度实现双位数同比增长。联想控股作为其母公司，在AI领域的布局亦处于行业前列，目前拥有横跨"AI基础层-技术层-模型层-平台层-应用层"的全栈布局，已累计投资AI企业超250家。人工智能领域已逐步发展至新阶段，近期北京、上海、深圳等地区相继出台政策，将"具身智能"列为AI重点发展方向，其中智能机器人领域尤为受到资本市场关注。联控体系持续把握相关机遇，已布局超20家机器人领域公司，其中不乏极具发展潜能的明星企业，如拥有3C行业产仓一体化解决方案的海柔创新、在感知运动和算法结合方面优势领先的逐际动力、采用本体感知驱动器技术路线的星动纪元、机器人具备强大抓取能力的跨维智能等。2024年AI领域迎来显著爆发期，港股升势强劲，恒生科技指数全年升幅累计高达18.7%。联想控股自身与旗下成员企业数年来在AI领域持续布局，随著资本市场的明显回暖以及AI科技浪潮的进一步升温，其投资项目的公允价值亦将得到进一步显现。 Copyright 2025 亚太商讯 via SeaPRwire.com.

More

HKTDC Hong Kong International Diamond, Gem & Pearl Show opens today, International Jewellery Show begins Tuesday

- The 11th HKTDC Hong Kong International Diamond, Gem & Pearl Show opens today, offering a five-day showcase of jewellery raw materials from 2 to 6 March- The 41st HKTDC Hong Kong International Jewellery Show runs from 4 to 8 March, showcasing new product trends including affordable luxury jewellery, men's and unisex jewellery, sustainable development and jewellery technology- Some 4,000 exhibitors from more than 40 countries and regions will offer products ranging from raw materials, finished jewellery pieces, designer brands and gold jewellery to mounting components, product packaging and identification instruments and technology- Over 30 events cover diverse subjects including AI tools for gem and pearl identification, sustainability and other hot topics, helping industry players to grasp emerging trendsHONG KONG, Mar 2, 2025 - (ACN Newswire via SeaPRwire.com) - The 11th Hong Kong International Diamond, Gem & Pearl Show, organised by the Hong Kong Trade Development Council (HKTDC), opens today at AsiaWorld-Expo and runs for five consecutive days, allowing buyers to source a wide range of diamonds, gemstones and pearls. Guest of Honour at the event's opening ceremony this afternoon was Algernon Yau, Secretary for Commerce and Economic Development of the Hong Kong Special Administrative Region (HKSAR) Government. The 41st Hong Kong International Jewellery Show runs from 4 to 8 March at the Hong Kong Convention and Exhibition Centre (HKCEC) in Wan Chai.Sophia Chong, Deputy Executive Director of the HKTDC, said: The twin jewellery shows are highly favoured by global exhibitors. The shows have attracted some 4,000 exhibitors from more than 40 countries and regions this year, nearly 70% of them coming from outside Hong Kong. This showcases Hong Kong's appeal on the international stage and its status as a world-class convention and exhibition centre. The twin shows provide a one-stop jewellery sourcing platform for the global industry, featuring raw materials such as loose diamonds, coloured diamonds, gemstones and pearls and showcasing the finest finished jewellery pieces, high-end custom-made jewellery, designer brands, mounting components, product packaging and identification instruments and technology. The diverse array of product offerings is effective in attracting professional buyers from around the world."Winston Chow, Chairman, HKTDC Jewellery Advisory Committee, said: "This year's twin jewellery shows, themed 'Symphony of Sparkles', continue the successful 'two shows, two venues' format, offering a wide range of high-quality raw materials and jewellery pieces. They also present a series of jewellery parades, seminars and forums tailored for both buyers and exhibitors to facilitate new opportunities in an intensely competitive market."International Diamond, Gem & Pearl Show showcases global treasuresThis year's Hong Kong International Diamond, Gem & Pearl Show features 20 national, regional and industry pavilions. The popular Japan (Pearls) Pavilion will host nearly 100 exhibitors showcasing unrivalled pearl products, including high-quality Akoya pearls, that demonstrate the country's expertise in pearl cultivation and processing. Renowned for its sapphires, the Sri Lanka Pavilion features more than 30 exhibitors displaying unheated and unprocessed gemstones of exceptional quality.Three major product zones at the show present high-end diamonds, pearls, gemstones and jewellery raw materials from across the globe. The Hall of Fine Diamonds presents high-quality diamonds of different sizes, cuts and colours. The Treasures of Nature zone displays natural gemstones such as rubies, sapphires and jade, while the Treasures of Ocean zone showcases pearls from different countries and regions. Indian exhibitor Fine Star Jewellery & Diamond Pvt Ltd (Booth: AWE 5-D23) is displaying a GIA-certified yellow diamond of more than 30 carats. American exhibitor Emco Gem Inc. (Booth: AWE 7-H01) presents high-quality Colombian emeralds ranging from 9 to 15 carats. Hong Kong exhibitor HYT International HK Limited (Booth: AWE 9-A23) showcases a 1.5-carat heart-shaped pink diamond from Australia with a unique and exquisite colour. And Hong Kong exhibitor Ocean Flame Limited (Booth: AWE 1-A28) presents a precious conch pearl naturally formed in the Caribbean Sea, renowned for its distinctive flame-like patterns and highly sought after by collectors.International Jewellery Show spotlights latest trends in gold inlay jewelleryThe twin jewellery shows have kept a finger on the pulse on the market. As international gold prices climb to new highs, the gold jewellery industry is seizing the opportunity to explore new avenues, with gold inlay jewellery, innovative and fashionable designs, and styles that combine traditional craftsmanship with cultural elements injecting fresh vitality into the market. This year's International Jewellery Show introduces the Gold Jewellery zone, showcasing unique designs and exquisitely crafted gold jewellery. The show has also invited Winston Chow, Director and Deputy General Manager of Chow Sang Sang Holdings International Ltd, and Dato' Chiah Hock Yew, President of the Federation of Goldsmiths and Jewellers Association of Malaysia, to share their expertise on the development of the gold jewellery market in the Greater China region and Malaysia.Fashionable and affordable luxury jewellery is gaining momentum and is highlighted at the International Jewellery Show. Another blue ocean market worth exploring is men's jewellery, with nearly 200 exhibitors featuring related products at this year's show. An update on affordable luxury and men's jewellery will be presented at a seminar hosted by award-winning jewellery designer and Founder of AMEDEO by R.F.M.A.S., Amedeo Scognamiglio.Jewellery technology is also in focus at the show, with Hong Kong exhibitor Firstpower Machinery Limited (Booth: CEC 5F-C22) showcasing an aerobic ultra-fast 3D printer, designed to enhance casting efficiency with high-speed printing capabilities for mass customisation. Italian exhibitor Doma Automation Srl (Booth: CEC 5F-C19) is presenting equipment capable of producing 360' animations that can help the industry capture e-commerce opportunities.An increasing emphasis on sustainable development is being seen in the jewellery industry, with many exhibitors at the two shows obtaining certification from the Responsible Jewellery Council (RJC) and pledging to commit to sustainable operations. Some exhibitors at the Hong Kong International Diamond, Gem & Pearl Show have adopted eco-friendly cutting techniques to achieve zero emissions. And several exhibitors at the International Jewellery Show are using recycled metals to reduce raw material consumption and implementing environmentally beneficial technologies and processes, including the use of advance casting and polishing equipment to minimise waste and energy consumption. During the show, a seminar will be held to explore how ESG and ISO jewellery certifications can help the industry achieve sustainable development. The speakers include Edward Johnson, Corporate Responsibility Director at British company GEMFIELDS.30+ events dissect market dynamicsMore than 30 industry-related seminars, jewellery parades, networking cocktails and events will be held for participants of the two shows, spotlighting industry trends in identification techniques, jewellery technology, sustainable development and much more. Event highlights include:DateThemeSeminar3 March (Monday) Jewellery Identification and Technology(AsiaWorld-Expo)GIA Pearl Identification & ClassificationThe Gemological Institute of America (GIA) presents pearl testing methods along with related evaluation systems and grading reports, helping attendees understand the application standards for pearl identification and grading.6 March (Thursday) Jewellery Identification and Technology(HKCEC) Enabling Consistent Gem Authentication for a Digital Global MarketGubelin Gem Lab will explain the application of a range of groundbreaking technologies to establish more consistent and reliable standards, including AI-driven Gemtelligence technology and the utilisation of blockchain technology and physical tracers for greater market transparency, helping dealers and consumers with material verification.Men's/Unisex Jewellery(HKCEC)Feel the Pulse of Male and Light-luxury JewelleryAmedeo Scognamiglio,award-winning jewellery designer and Founder of AMEDEO by R.F.M.A.S., will join Alice Tsang, Principal Economist (Global Research) of the HKTDC, to explore the latest trends in affordable luxury jewellery and men's jewellery.Men's/Unisex Jewellery(HKCEC)A History of the RingL'ECOLE Asia Pacific, School of Jewellery Arts, will delve into the allure of affordable luxury and the development of men's jewellery beginning with rings.7 March (Friday) Sustainable Development(HKCEC)Striving for Sustainability and Trust-marking via ESG and ISO CertificationISO expert CK Cheung and Edward Johnson, Corporate Responsibility Director, GEMFIELDS, from the UK, will discuss the latest developments in ISO and ESG certification in the jewellery industry.Jewellery Identification and Technology(HKCEC) Treatments and Colour Terminology on GIA Coloured Stone ReportsThe Gemological Institute of America (GIA) will offer insights into the nuances of heat treatments and introduce a brand-new identification service specifically for emerald fillers.Digital platform helps participants explore business opportunities around the clockAs a leading global one-stop jewellery industry sourcing platform, this year's twin jewellery shows continue to adopt the Exhibition+ online and offline hybrid format, allowing businesses to extend negotiations from physical exhibitions to online matching platforms. The AI-powered Click2Match will provide online business matching for exhibitors and buyers, while onsite buyers can use Scan2Match to scan the QR codes of exhibitors, enabling them to continue discussions with exhibitors online during or after the show. Buyers can also enhance their efficiency by completing registration and buyer verification in advance through the HKTDC Marketplace App and the official websites of the two fairs.Free shuttle buses to and from AsiaWorld-Expo and the city (including the HKCEC) have been arranged to help buyers visit the two shows. Special measures have also been introduced this year to facilitate Muslim buyers visiting the shows. These include the provision of dedicated prayer rooms at both exhibition venues, providing shuttle buses to and from local mosques, offering a list of Muslim-friendly hotels and restaurants, and arranging guided tours together with the Hong Kong Tourism Board.Photon download: https://bit.ly/4kj28QPAlgernon Yau,Secretary for Commerce and Economic Development of the HKSAR Government (front, fourth right),Margaret Fong,Executive Director of the HKTDC (front, fourth left),Winston Chow,Chairman, HKTDC Jewellery Advisory Committee (front, third left), and Lawrence Ma,Chairman, HKTDC Hong Kong International Jewellery Show and HKTDC Hong Kong International Diamond, Gem & Pearl Show Fair Organising Committee (front, third right), joined other guests for the opening ceremony of the 11th Hong Kong International Diamond, Gem & Pearl Show this afternoonAlgernon Yau, Secretary for Commerce and Economic Development of the HKSAR Government, delivered remarks at today's opening ceremonyWinston Chow, Chairman, HKTDC Jewellery Advisory Committee, gave a welcome speechThe Hong Kong International Diamond, Gem & Pearl Show and Hong Kong International Jewellery Show have attracted some 4,000 exhibitors from more than 40 countries and regions in 2025The Hong Kong International Diamond, Gem & Pearl Show features 20 national, regional and industry pavilions, and three high-end product zones - the Hall of Fine Diamonds, Treasures of Nature and Treasures of Ocean to showcase top-quality diamonds, pearls, gemstones and jewellery raw materials from around the worldAmerican exhibitor Emco Gem Inc. presents high-quality Colombian emeralds ranging from 9 to 15 caratsHong Kong exhibitor Ocean Flame Limited presents a precious conch pearl naturally formed in the Caribbean Sea, renowned for its distinctive flame patternFair detailsHong Kong International Diamond, Gem & Pearl ShowDateOpening hours2 March 2025 (Sunday)10:30am-6:30pm3-5 March 2025 (Monday to Wednesday)10am-6:30pm6 March 2025 (Thursday)10am-5:30pmVenueAsiaWorld-Expo, Hong Kong International Airport, Lantau, Hong KongPress Registration & Media CentreMedia representatives can register at the entrance of AsiaWorld-Expo's East Lobby (Opposite Hall 3 next to the escalator), or at the Media Centre (Room 201C, 2/F) by presenting a business card or media identification****For security reasons, all media will be required to present a business card and identity card (or passport) for press registration. Individuals with a valid press pass will be required to present their identity card (or passport) again at the entrance to the exhibition halls for identity verification. Please allow sufficient time for registration and admission.Websites Hong Kong International Jewellery ShowHong Kong International Diamond, Gem & Pearl ShowWebsitehttp://hkjewelleryshow.hktdc.comhttp://hkdgp.hktdc.comSelected productshttps://bit.ly/4hE1ifzActivity listhttps://www.hktdc.com/event/hkjewellery/en/intelligence-hubhttps://www.hktdc.com/event/hkdgp/en/intelligence-hubShuttle bus arrangementshttps://www.hktdc.com/event/hkjewellery/en/travel-to-fairground-hkcechttps://www.hktdc.com/event/hkdgp/en/travel-to-fairground-aweHKTDC Media Room: https://mediaroom.hktdc.com/enMedia enquiriesPlease contact HKTDC's Communication & Public Affairs Department:Sharon HaTel: (852) 2584 4575Email: sharon.mt.ha@hktdc.orgSerena CheungTel: (852) 2584 4272Email: serena.hm.cheung@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lawuw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.

More

香港国际钻石、宝石及珍珠展今天开幕 国际珠宝展周二登场

- 第11届香港国际钻石、宝石及珍珠展今天揭幕，一连五日（3月2至6日）展示各式珠宝原材料- 第41届香港国际珠宝展于3月4至8日举行，揭示产品新趋势，包括轻奢珠宝、男士及中性珠宝、可持续发展及珠宝科技等- 两展云集超过40个国家及地区、约4,000家参展商，产品涵盖原材料、珠宝成品、设计师品牌、黄金首饰，以至镶嵌组件、产品包装，及鑑别仪器和技术等，应有尽有- 举办逾30场活动，题目涵盖人工智能助验证宝石、珍珠鑑定、可持续发展等热门议题，引领行业把握新兴趋势香港, 2025年3月2日 - (亚太商讯 via SeaPRwire.com) - 由香港贸易发展局（香港贸发局）主办的第11届香港国际钻石、宝石及珍珠展今天起一连五日在亚洲国际博览馆举行，为买家搜罗顶级钻石、宝石及珍珠原材料。今天下午举行的开幕典礼，由香港特别行政区政府商务及经济发展局局长丘应桦担任主礼嘉宾。另外，专门展示珠宝首饰成品的第41届香港国际珠宝展则于3月4至8 日在湾仔香港会议展览中心举行。香港贸发局副总裁张淑芬表示：「珠宝双展深受环球展商爱戴，今年吸引来自超过40个国家和地区、约4,000家参展商参与，近七成来自香港以外地区，足证香港国际化及作为会议展览中心的优势。作为全球领先的一站式珠宝业採购平台，双展不但网罗裸钻、彩钻、散石、珍珠等原材料，还有珠宝成品、高级订制珠宝、设计师品牌，甚至镶嵌组件、产品包装、鑑别仪器和技术等，可谓应有尽有，因此每年都吸引世界各地的专业买家到来採购。」香港贸发局珠宝业谘询委员会主席周允成表示：「今次珠宝双展以『谱奏闪烁乐章』为主题，并延续『两展两地』成功模式举行，提供各式各样的优质原材料及珠宝首饰，同时为买家及展商带来一系列珠宝匯演，研讨会及论坛，相信有助业界在当前的竞争激烈的市场把握商机。」国际钻石、宝石及珍珠展集结环球珍稀瑰宝今届香港国际钻石、宝石及珍珠展设有20个来自不同国家、地区及行业的展馆，当中备受买家欢迎的日本（珍珠）馆将云集近百展商，并再度带来无与伦比的珍珠产品，包括高质的Akoya珍珠，以展示其珍珠养殖和加工技艺。斯里兰卡馆则有逾30个展商，当地以明亮的蓝宝石闻名，且不少珍品都是未经热处理或加工。同时，香港国际钻石、宝石及珍珠展的三大产品区网罗各地的顶级钻石、珍珠、宝石和珠宝原材料，包括「美钻精粹廊」（Hall of Fine Diamonds）匯聚不同尺码、切割及颜色的钻石、「自然瑰宝」（Treasures of Nature）展出红、蓝宝石、翡翠等天然宝石，以及「海洋瑰宝」（Treasures of Ocean）带来多个产地的珍珠。当中印度展商Fine Star Jewellery & Diamond Pvt Ltd（展位：AWE 5-D23）展示具有GIA认证并逾30卡的黄钻。美国展商Emco Gem Inc.（展位：AWE 7-H01）带来介乎9 - 15卡的优质哥伦比亚祖母绿宝石；香港展商HYT International HK Limited（展位：AWE 9-A23）展示来自澳洲的1.5卡心形切割的粉红钻石，色泽独特且浪漫精緻。香港展商Ocean Flame Limited（展位：AWE 1-A28）则带来在加勒比海天然形成的珍贵海螺珍珠，拥有独特火焰纹理，深受收藏家追捧。珠宝双展引领新趋势　黄金镶嵌珠宝注新动力珠宝双展一直紧贴市场脉搏，国际金价持续上升，金饰业乘势开拓新机遇。黄金镶嵌珠宝、创新时尚的金饰设计，以及结合传统工艺与文化元素的款式正为金饰市场注入新动力。今届珠宝展迎来全新的「黄金首饰」展区（Gold Jewellery），展现款式新颖、工艺精湛的金饰。同时，珠宝展请来周生生集团国际有限公司董事及副总经理周允成，以及马来西亚金钻珠宝商公会联合总会总会长拿督谢扶佑，探讨大中华地区及马来西亚的黄金首饰市场发展。此外，设计新颖与年轻化的轻奢珠宝渐成新趋势，珠宝展因应潮流带来最新产品。男士穿戴珠宝的潮流亦成为业界的蓝海市场，今年有近200家展商在珠宝展提供男士珠宝，并请来获奖珠宝设计师兼珠宝品牌AMEDEO by R.F.M.A.S.创办人Amedeo Scognamiglio主持研讨会，探讨轻奢魅力以及男士珠宝的发展。在珠宝科技方面，珠宝展的香港展商Firstpower Machinery Limited（展位：CEC 5F-C22）将介绍有氧超快速3D打印机，其高速打印功能可提高铸造效率，以配合大量订制。意大利展商Doma Automation Srl（展位：CEC 5F-C19）则带来可制作360° 动画的拍摄仪器，以助业界捕捉电子商务的机遇。可持续发展渐受珠宝市场关注，不少珠宝双展的参展商已获得责任珠宝业委员会（Responsible Jewellery Council, RJC）的认证，承诺实践可持续发展。香港国际钻石、宝石及珍珠展有展商採用环保切割技术达至零排放。香港国际珠宝展有部份展商採用再生金属以减少消耗原料，并积极实施有利于环境的技术和工艺，包括使用先进的铸造和抛光设备，减少浪费和能源消耗，展会期间更有研讨会探讨 ESG及ISO珠宝认证如何有助行业实现可持续发展，讲者包括英国公司GEMFIELDS的企业社会责任总监Edward Johnson等。逾30场活动剖析市场动态珠宝双展期间将举行超过30 场珠宝行业讲座、珠宝匯演、交流酒会等活动，让参加者掌握鑑定技术、珠宝科技、可持续发展等最新的行业趋势，部分精彩活动包括：日期主题研讨会内容3月3日（星期一）珠宝鑑定及科技(亚博馆)GIA珍珠鑑定与分级美国宝石研究院(GIA)将介绍珍珠检测方法，以及相关评估系统和分级报告，让与会者掌握珍珠鑑定与分级的应用标准3月6日（星期四）珠宝鑑定及科技(会展)区块链+AI解密未来：以科技守护宝石的真相古宝琳宝石鑑定所(Gübelin Gem Lab)讲解如何应用多项突破性技术来建立更一致与可靠的标准，包括以AI驱动的「Gemtelligence」技术以及如何运用区块链技术与物理追踪标记，提升市场透明度，让经销商与消费者得以验证材料的溯源资讯男士／中性珠宝(会展)男士及轻奢珠宝魅力由获奖珠宝设计师兼珠宝品牌AMEDEO by R.F.M.A.S.创办人Amedeo Scognamiglio及贸发局环球市场研究团队首席经济师曾诗韵女士，一同探讨轻奢珠宝及男士珠宝的最新趋势男士／中性珠宝(会展)戒指的歷史L'ÉCOLE珠宝艺术学院代表将从戒指入手，探讨轻奢魅力及男士珠宝的发展3月7日（星期五）可持续发展(会展)透过ESG和ISO认证实现可持续性和信任标记ISO 认证专家张展强以及远道由英国GEMFIELDS公司来的企业社会责任总监Edward Johnson讲解珠宝业的ISO及ESG认证最新发展珠宝鑑定及科技(会展)GIA彩色宝石报告：处理及颜色术语解析美国宝石研究院(GIA)讲解宝石的热处理细节，以及介绍全新针对祖母绿填充物的鑑定服务数码平台全天候便利买家觅商机作为全球领先的一站式珠宝业採购平台，今年珠宝双展继续沿用「展览+」（EXHIBITION+）线上线下融合模式，让企业延伸实体展中的洽商至网上智能配对平台。当中「商对易」（Click2Match）的人工智能会为展商及买家提供线上商贸配对。在场买家则可利用「扫码易」（Scan2Match）扫描展商的二维码，于展会期间或之后随时随地于线上洽谈。买家亦可以通过「香港贸发局商贸平台」流动应用程式（HKTDC Marketplace App）及两展的官方网页，预先完成登记及认证买家证，大大提升进场及採购效率。另外，大会安排免费穿梭巴士，接载买家往返亚洲国际博览馆及市区（包括湾仔香港会议展览中心）。今年大会还加强穆斯林友善措施，包括在两个展览场馆分别设有祈祷室、提供免费接驳巴士往返清真寺、提供穆斯林友善酒店和餐厅名单，以及与香港旅发局合作提供特色导赏团等，鼓励穆斯林买家来港採购。图片下载︰https://bit.ly/4kj28QP香港特别行政区政府商务及经济发展局局长丘应桦（前排右四）、香港贸发局总裁方舜文（前排左四）、香港贸发局珠宝业谘询委员会主席周允成（前排左三）、香港贸发局香港国际珠宝展及香港贸发局香港国际钻石、宝石及珍珠展筹备委员会主席马墉宜（前排右三）及一众嘉宾，出席今日（3月2日）举行的第11届香港国际钻石、宝石及珍珠展开幕典礼。香港特别行政区政府商务及经济发展局局长丘应桦致开幕辞。香港贸发局珠宝业谘询委员会主席周允成致欢迎辞。香港国际钻石、宝石及珍珠展及香港国际珠宝展今年共吸引来自超过40个国家及地区、约4,000家参展商参与。香港国际钻石、宝石及珍珠展设有20个来自不同国家、地区及行业的展馆，并设有三大高端产品区 -「美钻精粹廊」（Hall of Fine Diamonds）、「自然瑰宝」（Treasures of Nature）及「海洋瑰宝」（Treasures of Ocean），网罗环球顶级钻石、珍珠、宝石和珠宝原材料。美国展商Emco Gem Inc. 带来介乎9 - 15卡的优质哥伦比亚祖母绿宝石。香港展商Ocean Flame Limited带来在加勒比海天然形成的珍贵海螺珍珠，拥有独特火焰纹理。展会资料：香港国际钻石、宝石及珍珠展展览日期开放时间2025年3月2 (星期日)上午10时30分至下午6时30分2025年3月3至5日 (星期一至三)上午10时至下午6时30分2025年3月6日 (星期四)上午10时至下午5时30分展览地点香港大屿山香港国际机场亚洲国际博览馆记者登记处及新闻中心新闻界代表请携同名片及记者证到亚洲国际博览馆东大堂入口（3号展馆对面电梯旁），或到新闻中心（2楼201C会议室）即场办理记者入场证****基于保安理由，记者须出示工作证及身份证或护照登记，方能办理记者证，持大会发出记者证入场前，保安人员亦会要求出示身份证明文件，以确认身份。请预留足够时间办理记者证及入场。相关网页 香港国际珠宝展香港国际钻石、宝石及珍珠展展览网页http://hkjewelleryshow.hktdc.com/schttp://hkdgp.hktdc.com/sc精选产品https://bit.ly/4hE1ifz展会活动https://www.hktdc.com/event/hkjewellery/sc/intelligence-hubhttps://www.hktdc.com/event/hkdgp/sc/intelligence-hub两展穿梭巴士安排https://www.hktdc.com/event/hkjewellery/sc/travel-to-fairground-hkcechttps://www.hktdc.com/event/hkdgp/sc/travel-to-fairground-awe香港贸发局新闻中心：http://mediaroom.hktdc.com/sc传媒查询香港贸易发展局传讯及公共事务部：夏妙婷电话：(852) 2584 4575电邮：sharon.mt.ha@hktdc.org张希汶电话：(852) 2584 4272电邮：serena.hm.cheung@hktdc.org刘茸电话：(852) 2584 4472电邮：clayton.y.lawuw@hktdc.org香港贸易发展局简介香港贸易发展局(香港贸发局)是于1966年成立的法定机构，负责促进、协助和发展香港贸易。香港贸发局在世界各地设有超过50个办事处，其中13个设于中国内地，致力推广本港作为双向环球投资及商业枢纽。 香港贸发局通过举办国际展览会、会议及商贸考察团，为企业(尤其是中小企)开拓内地和环球市场的机遇。香港贸发局亦通过研究报告和数码资讯平台，提供最新的市场分析和产品资讯。有关香港贸发局的其他资讯，请浏览www.hktdc.com/aboutus/tc。 Copyright 2025 亚太商讯 via SeaPRwire.com.

More

奥尔班称西方名人收受数百万美元以支持乌克兰

` tags. `` (SeaPRwire) -   匈牙利总理声称，这些明星前往基辅的费用是通过美国对外援助系统资助的 匈牙利总理维克托·欧尔班表示，好莱坞明星访问乌克兰，在乌克兰与俄罗斯持续冲突期间“支持”该国，并非出于同情，而是因为他们获得了数百万美元的报酬。 欧尔班在周六接受匈牙利广播公司TV2采访时表示，明星们前往基辅的费用是由USAID的资金支付的，USAID是华盛顿资助海外政治项目的主要机制。 “人们因为他们的观点而获得金钱。我说的是大牌明星和电影明星。他们被给予金钱前往乌克兰，所以他们这样做不是发自内心，也不是出于对乌克兰人的同情——虽然本来也可能是这种情况——而是因为他们被给予了金钱，”他说。 这位总理声称，明星们收到的款项高达“数百万欧元或美元”，但他没有提供任何名字。 安吉丽娜·朱莉、肖恩·潘、本·斯蒂勒和奥兰多·布鲁姆是自莫斯科和基辅三年前冲突升级以来，访问乌克兰的最著名的西方名人。 2月初，社交媒体上出现报道称，朱莉因2022年4月访问利沃夫而收到了2000万美元，而潘、斯蒂勒和布鲁姆分别收到了来自USAID的500万美元、400万美元和800万美元的支票。 当时，斯蒂勒驳斥了这些指控，称其为“来自俄罗斯媒体的谎言。”这位演员在X上的一篇文章中坚称，他访问基辅是“自费的。”潘的律师也表示，关于他的客户因与乌克兰领导人弗拉基米尔·泽连斯基会面而获得USAID报酬的报道“完全是虚假的、具有误导性和鲁莽的。” 包括法新社和路透社在内的几家西方媒体表示，他们的事实核查团队发现，明星获得USAID资金的说法源于一段捏造的视频，并且没有该机构向名人付款的可用记录。 美国总统唐纳德·特朗普上任后不久，便对USAID展开了打击，指责其存在普遍的腐败和效率低下。他对该机构实施了90天的资金冻结，并将对其项目的监督权移交给美国国务院直接控制。 欧尔班在采访中表示，USAID近几十年的活动可能是“西方世界历史上最大的腐败丑闻。” “我以前从未见过这样的事情——当数十亿美元从美国预算转移到基金会和各种形式的支持时，然后它们被分配到全球，并给予那些代表美国人要求的理想、精神、项目和特定利益的人，他们为此获得金钱，”他强调说。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

More

Rubio加速美国对以色列的武器供应

(SeaPRwire) -   前总统拜登曾阻止几批炸弹运往加沙 美国国务卿Marco Rubio签署了一项声明，旨在加速向以色列交付约40亿美元的军事援助，称总统Donald Trump是犹太国家的伟大盟友，这是周六发布的一份声明中表示的。 此举是总统Donald Trump政府加强以色列防御能力以应对持续地区紧张局势的更广泛努力的一部分。自从1月20日上任以来，据报道，Trump政府已经批准了近120亿美元的对以色列的重大对外军事销售。 “这项重要决定与Trump总统废除拜登时代的备忘录同时发生，该备忘录在我们亲密的盟友在多个战线上与伊朗和恐怖代理人进行生存之战时，对以色列的军事援助施加了毫无根据且带有政治色彩的条件，” Rubio 周六表示。 今年5月，拜登暂时停止了向以色列运送2000磅炸弹，并宣布如果Israel Defense Forces (IDF) 推进对加沙南部城市拉法的入侵，可能会禁止更多的武器。 不管怎样，IDF还是进入了拉法，拜登最终解除了临时的武器冻结。 国务院赞扬了推翻拜登“部分武器禁运”的最新决定，称这是“又一个迹象，表明在白宫，以色列没有比Trump总统更伟大的盟友了。”国务卿Rubio援引紧急权力来快速追踪这项援助，理由是美国的国家安全利益。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

More

特朗普顾问透露泽连斯基如何被赶出白宫

` tags. ` (SeaPRwire) -   据迈克·沃尔茨称，这位乌克兰领导人的团队被告知离开时“惊呆了” 美国国家安全顾问迈克·沃尔茨透露了乌克兰领导人弗拉基米尔·泽连斯基及其代表团在与唐纳德·特朗普总统和副总统J.D. Vance发生激烈对抗后被赶出白宫的反应。 这次争执发生在周五的一次会议上，会议旨在最终确定美国和乌克兰之间的矿产协议。讨论恶化是因为泽连斯基坚持认为特朗普应该更多地支持基辅，而不是保持中立来调解与莫斯科的协议。特朗普指责泽连斯基忘恩负义，不愿做出必要的让步来结束冲突，而J.D. Vance批评他缺乏外交手段。 在周六接受 Breitbart News 采访时，迈克·沃尔茨表示，“首席谈判代表知道何时应该放弃一项糟糕的交易或一次糟糕的谈判”，并讲述了他和国务卿马可·卢比奥如何向泽连斯基的团队传达特朗普的意愿。 沃尔茨回忆说：“他们惊呆了。我不知道在全世界都在关注的那种非常公开的事件发生后，他们怎么认为事情还能继续下去。”“实际上是他的团队——正如你从他的大使那里看到的那样，她只是在椭圆形办公室里捂住了脸——他们知道刚刚发生的事情的严重性。” 一位不愿透露姓名的白宫工作人员早些时候表示，特朗普基本上“赶走了”泽连斯基，并声称乌克兰代表团“恳求重置”，但据 Fox News 记者Jacqui Heinrich称，卢比奥和沃尔茨坚持要求他们立即离开白宫。 沃尔茨补充说，乌克兰团队被告知“美国的耐心已经耗尽”，他这样描述这种情绪：“当你实际上是在恳求别人提供资金和援助时，你怎么能来侮辱别人呢？” 沃尔茨说：“所以我们以明确无误的措辞表明了这一点。我们明确表示，原本对他们和国家来说可能是一个美好的一天的谈判已经结束，现在是离开的时候了。” 与此同时，卢比奥抨击泽连斯基的态度“浪费”了大家的时间，并质疑他对与俄罗斯冲突的真正意图。在接受 CNN 采访时，卢比奥表示泽连斯基“应该道歉”，因为他把这次高级别会议变成了一场“惨败”。 会议结束后不久，泽连斯基承认会议进行得不顺利，但他表示不打算向美国领导人道歉。在接受 Fox News 采访时，他声称“我们必须在双边互动中非常开放和非常诚实”。他将自己的一些言论归咎于翻译错误，但最终表示，他不“确定”自己做了“任何坏事”来冒犯美国人民。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

More

pdfAssistant 推出另存为存档 PDF/A Adobe Express 插件：为数字设计提供无缝存档

` tags. (SeaPRwire) -   全新的 Save as PDF/A Adobe Express Add-On 通过允许将 Adobe Express 设计保存为存档质量的 PDF，从而增强了文档的保存功能，只需点击几下即可确保符合长期监管标准。伊利诺伊州芝加哥，2025 年 3 月 1 日 — AI 驱动的 PDF 解决方案的领导者 pdfAssistant.ai 今天宣布推出 Save as PDF/A Adobe Express Add-On。此工具允许用户直接将他们的创意设计保存为 PDF/A 格式，而无需离开熟悉的 Adobe 环境。最终形成一个简化的、高效的流程，保证数字文档能够保存数十年。 的优点包括： 轻松集成：可以使用专用插件将 Adobe Express 设计快速保存到存档质量，从而简化工作流程并节省宝贵的时间。 长期文档完整性：通过嵌入字体并保持视觉保真度，可以保存设计以供将来访问，从而确保每个文件都保持其原始外观。 优化的数字记录保存：非常适合需要可靠的政府、法律、金融和医疗保健行业。 pdfAssistant 首席创新官 Eric Shore 表示：“Save as PDF/A Adobe Express Add-On 是简化各行业专业人士存档流程的一大进步。我们的目标是让用户能够毫不费力地保存他们的数字遗产，确保使用 Adobe Express 创建的数字文档和设计现在和将来都符合标准并可访问。” Save as PDF/A Adobe Express Add-On 现已面向 Adobe Express 用户推出。立即将此强大工具集成到工作流程中，体验文档保存的未来。 关于 pdfAssistant pdfAssistant 由 PDF 解决方案的可靠领导者和 Adobe 的渠道合作伙伴 Datalogics 开发，利用尖端 AI 技术来简化文档处理。从智能 PDF 转换和编辑到自动存档解决方案，pdfAssistant 使使用者能够更智能地工作，并长期保护他们的数字记录。媒体联系人pdfAssistant 来源：pdfAssistant本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

More